Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma
Open Access
- 23 July 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-8
Abstract
Although several biomarkers can be used to distinguish cholangiocarcinoma (CCA) from healthy controls, differentiating the disease from benign biliary disease (BBD) or pancreatic cancer (PC) is a challenge. CCA biomarkers are associated with low specificity or have not been validated in relation to the biological effects of CCA. In this study, we quantitatively analyzed 15 biliary bile acids in CCA (n = 30), BBD (n = 57) and PC (n = 17) patients and discovered glycocholic acid (GCA) and taurochenodeoxycholic acid (TCDCA) as specific CCA biomarkers. Firstly, we showed that the average concentration of total biliary bile acids in CCA patients was quantitatively less than in other patient groups. In addition, the average composition ratio of primary bile acids and conjugated bile acids in CCA patients was the highest in all patient groups. The average composition ratio of GCA (35.6%) in CCA patients was significantly higher than in other patient groups. Conversely, the average composition ratio of TCDCA (13.8%) in CCA patients was significantly lower in all patient groups. To verify the biological effects of GCA and TCDCA, we analyzed the gene expression of bile acid receptors associated with the development of CCA in a CCA cell line. The gene expression of transmembrane G protein coupled receptor (TGR5) and sphingosine 1-phosphate receptor 2 (S1PR2) in CCA cells treated with GCA was 8.6-fold and 3.4-fold higher compared with control (untreated with bile acids), respectively. Gene expression of TGR5 and S1PR2 in TCDCA-treated cells was not significantly different from the control. Taken together, our study identified GCA and TCDCA as phenotype-specific biomarkers for CCA.Keywords
Funding Information
- National Research Foundation of Korea (2015M1A5A1037196, 2016M1A3A3A02018239, 2017M3A9B6062984, 2015R1C1A1A01053048, 2017M3A9E4077225)
This publication has 39 references indexed in Scilit:
- Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signalingAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2013
- Pleiotropic Roles of Bile Acids in MetabolismCell Metabolism, 2013
- Impact of bile acids on the growth of human cholangiocarcinoma via FXRJournal of Hematology & Oncology, 2011
- Clinical diagnosis and staging of cholangiocarcinomaNature Reviews Gastroenterology & Hepatology, 2011
- Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinomaHPB, 2011
- Advances in the treatment of metastatic or unresectable biliary tract cancerAnnals of Oncology, 2010
- Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopyHPB, 2010
- Bile acids: analysis in biological fluids and tissuesJournal of Lipid Research, 2009
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 #Hepatology, 2009
- CEACAM6 gene expression in intrahepatic cholangiocarcinomaBritish Journal of Cancer, 2006